Serina Therapeutics, Inc. Preferred Stock, Value, Issued
Serina Therapeutics, Inc. (SER) had Preferred Stock, Value, Issued of $0 as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:PreferredStockValue · last filed 2026-08-13
- 2026-06-30: Preferred Stock, Value, Issued $0.00.
- 2026-03-31: Preferred Stock, Value, Issued $4.94M.
- 2025-12-31: Preferred Stock, Value, Issued $4.94M.
- 2025-09-30: Preferred Stock, Value, Issued $4.94M.
| Period end | Preferred Stock, Value, Issued |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 |
| 2026-03-31 | $4.94M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $4.94M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $4.94M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $4.94M 10-Q · filed 2025-08-11 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-25 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 |
| 2023-12-31 | $0.00 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |